Cargando…
Navigating facilitated regulatory pathways during a disease X pandemic
In 2018, the Bill and Melinda Gates Foundation convened over thirty subject matter experts in clinical development, manufacturing, and regulatory assessment to determine how the development and approval of medical countermeasures could be accelerated in the event of Disease X. Disease X is the resul...
Autores principales: | Simpson, Shmona, Chakrabarti, Ajoy, Robinson, David, Chirgwin, Keith, Lumpkin, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584587/ https://www.ncbi.nlm.nih.gov/pubmed/33110630 http://dx.doi.org/10.1038/s41541-020-00249-5 |
Ejemplares similares
-
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine
por: Thiel, Natalie, et al.
Publicado: (2021) -
Disease X: accelerating the development of medical countermeasures for the next pandemic
por: Simpson, Shmona, et al.
Publicado: (2020) -
Pandemic Best Regulatory Practices: An Urgent Need in the COVID‐19 Pandemic
por: Lumpkin, Murray M., et al.
Publicado: (2020) -
The COVID‐19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics
por: Soumyanarayanan, Uttara, et al.
Publicado: (2021) -
The World Health Organization Prequalification Program and Clinical Pharmacology in 2030
por: Blaschke, Terrence F., et al.
Publicado: (2019)